Park Ha Biological Technology Co., Ltd. Ordinary Shares
BYAH
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
Last trade$1.58
Day change+$0.10 (+6.76%)
Day range$1.29 – $2.18
Volume748,246
Market cap$1M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for BYAH.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for BYAH.
Recent news
Company coverage with links to the original publishers.
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025 are encouraged to join the case, with a lead plaintiff deadline of September 28, 2026.
A securities class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. for allegedly making materially false statements and failing to disclose a fraudulent stock promotion scheme involving social media misinformation and artificially manipulated trading activity. Investors who purchased securities between December 27, 2024 and July 8, 2025 are encouraged to seek legal counsel before the September 28, 2026 lead plaintiff deadline.
Rosen Law Firm announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) for investors who purchased securities between December 27, 2024 and July 8, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and artificially manipulated trading activity. The lead plaintiff deadline is September 28, 2026.
Rosen Law Firm has filed class action lawsuits against Lincoln Educational Services Corporation and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Lincoln Educational Services made false statements about its admissions process and student conversion rates, resulting in misleading statements about business operations and prospects. Investors who purchased securities during the class period may be entitled to compensation.
Rosen Law Firm announces securities class action lawsuits against Park Ha Biological Technology Co., Ltd. (PHH, BYAH), ARS Pharmaceuticals, Inc. (SPRY), and Beta Bionics, Inc. (BBNX). The firm is seeking lead plaintiffs with losses exceeding $100,000 before the September 28, 2026 deadline. Park Ha faces allegations of fraudulent stock promotion schemes, misleading statements, and artificially manipulated trading activity.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.